Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1070 | 938 | 1103 | 1246 | 1509 | 2029 |
Fund Return | 7.05% | -6.17% | 10.29% | 7.62% | 8.58% | 7.33% |
Place in category | 578 | 934 | 790 | 8 | 159 | 160 |
% in Category | 58 | 93 | 84 | 2 | 33 | 58 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 713.69M | 8.06 | 5.53 | 11.68 | ||
Seligson & Co Global Top 25 Brands | 713.69M | 8.06 | 5.52 | 11.64 | ||
Seligson & Co North American A | 534.76M | 26.70 | 13.09 | 14.31 | ||
Seligson North American B | 534.76M | 26.69 | 13.09 | 14.29 | ||
FI4000283031 | 385.74M | 25.38 | 13.01 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest MediLife T | 553.62K | 13.52 | 6.57 | 11.43 | ||
Danske Invest MediLife K | 89.69M | 13.52 | 6.56 | 11.42 | ||
Seligson Global Top 25 Pharmac B | 271.45M | 7.05 | 7.62 | 7.36 | ||
LahiTapiola Hyvinvointi A | 133.66M | 3.50 | -0.23 | 7.69 | ||
LahiTapiola Hyvinvointi B | 133.66M | 3.50 | -0.23 | 7.69 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 6.97 | 91.93 | -1.87% | |
Roche Holding Participation | CH0012032048 | 6.95 | 253.50 | -0.31% | |
J&J | US4781601046 | 6.55 | 155.78 | +0.39% | |
Pfizer | US7170811035 | 6.39 | 26.17 | +2.03% | |
Merck&Co | US58933Y1055 | 6.21 | 101.16 | +2.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review